Publikationen 2013

Agarwal N, Bellmunt J, Maughan BL, Boucher KM, Choueiri TK, Qu AQ, Vogelzang NJ, Fougeray R, Niegisch G, Albers P, Wong YN, Ko YJ, Sridhar SS, Tantravahi SK, Galsky MD, Petrylak DP, Vaishampayan UN, Mehta AN, Beer TM, Sternberg CN, Rosenberg JE, Sonpavde G.
Six-Month Progression-Free Survival as the Primary Endpoint to Evaluate the Activity of New Agents as Second-line Therapy for Advanced Urothelial Carcinoma. Clin Genitourin Cancer.
2013 Sep 28. pii: S1558-7673(13)00213-9. doi: 10.1016/j.clgc.2013.09.002. [Epub ahead of print]
PubMed PMID: 24220220.

Albers P.
Epidemiological Studies Are Important to Trigger Health Care Decisions.
Eur Urol. 2013 Nov 28. pii: S0302-2838(13)01281-5. doi: 10.1016/j.eururo.2013.11.032. [Epub ahead of print]
PubMed PMID: 24314828.

Albers P, Arsov C. Re: Strategy for Detection of Prostate Cancer Based on Relation Between Prostate Specific Antigen at Age 40-55 and Long Term Risk of Metastasis: Case control Study.
Eur Urol. 2013 Oct;64(4):681-682.

Arsov C, Becker N, Hadaschik BA, Hohenfellner M, Herkommer K, Gschwend JE, Imkamp F, Kuczyk MA, Antoch G, Kristiansen G, Siener R, Semjonow A, Hamdy FC, Lilja H, Vickers AJ, Schröder FH, Albers P.
Prospective randomized evaluation of risk-adapted prostate-specific antigen screening in young men: the PROBASE trial.
Eur Urol. 2013 Dec;64(6):873-5. doi: 10.1016/j.eururo.2013.05.022. Epub 2013 May 14.
PubMed PMID: 23707067.

Barski D, Richter M, Winter C, Arsov C, de Geeter P, Rabenalt R, Albers P.
Holmium laser ablation of the prostate (HoLAP): intermediate-term results of 144 patients.
World J Urol. 2013 Oct;31(5):1253-9. doi: 10.1007/s00345-012-0901-6. Epub 2012 Jul 11.
PubMed PMID: 22782618.

Berger LA, Lorch A, Hentrich M, Kopp HG, Gauler TC, Beyer J, de Wit M, Mayer F, Bokemeyer C, Honecker F, Lryselova N, Oechsle K.
First-salvage treatment in patients with recurrent or refractory advanced germ cell cancer after cisplatin-based chemotherapy - A database of the German Testicular Cancer Study Group.
Onkologie 2013 Oct;36(S7):113-114.

Beyer J, Albers P, Altena R, Aparicio J, Bokemeyer C, Busch J, Cathomas R, Cavallin-Stahl E, Clarke NW, Claßen J, Cohn-Cedermark G, Dahl AA, Daugaard G, De Giorgi U, De Santis M, De Wit M, De Wit R, Dieckmann KP, Fenner M, Fizazi K, Flechon A, Fossa SD, Germá Lluch JR, Gietema JA, Gillessen S, Giwercman A, Hartmann JT, Heidenreich A, Hentrich M, Honecker F, Horwich A, Huddart RA, Kliesch S, Kollmannsberger C, Krege S, Laguna MP, Looijenga LH, Lorch A, Lotz JP, Mayer F, Necchi A, Nicolai N, Nuver J, Oechsle K, Oldenburg J, Oosterhuis JW, Powles T, Rajpert-De Meyts E, Rick O, Rosti G, Salvioni R, Schrader M, Schweyer S, Sedlmayer F, Sohaib A, Souchon R, Tandstad T, Winter C, Wittekind C.
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer.
Ann Oncol. 2013 Apr;24(4):878-88. doi: 10.1093/annonc/mds579. Epub 2012 Nov 14.
PubMed PMID: 23152360; PubMed Central PMCID: PMC3603440.

Bokemeyer C, Albers P, Schmidberger H, Hoffken K.
Any more Questions?
Onkologe 2013 Jul;19(7):542-542.

Bramann EL, Willenberg HS, Hildebrandt B, Müller-Mattheis V, Schott M, Scherbaum WA, Haase M.
Griseofulvin inhibits the growth of adrenocortical cancer cells in vitro.
Horm Metab Res. 2013 Apr;45(4):297-300. doi: 10.1055/s-0032-1327642. Epub 2012 Oct 30.
PubMed PMID: 23111828.

Brehmer B, Kauffmann C, Giessing M, Fornara P, Engehausen D, Wunderlich H, Heynemann H, Dreikorn K, Heidenreich A.
[The 20th annual conference of the Working Group on Kidney Transplantation of the Academy of German Urologists in Aachen].
Urologe A. 2013 Apr;52(4):580-3. doi: 10.1007/s00120-013-3154-0. German.
PubMed PMID: 23483274.

Engelken F, Friedersdorff F, Fuller TF, Magheli A, Budde K, Halleck F, Deger S, Liefeldt L, Hamm B, Giessing M, Diederichs G.
Pre-operative assessment of living renal transplant donors with state-of-the-art imaging modalities: computed tomography angiography versus magnetic resonance angiography in 118 patients.
World J Urol. 2013 Aug;31(4):983-90. doi: 10.1007/s00345-012-1022-y. Epub 2013 Jan 8.
PubMed PMID: 23297099.

Esch L, Arsov C, Albers P.
PSA-based screening. Boon or bane?
Onkologe 2013 Sep;19(9):705-710.

Friedersdorff F, Roller C, Klein G, Werthemann P, Cash H, Budde K, Slowinski T, Kempkensteffen C, Busch J, Fuller TF, Giessing M.
Outcome of expanded criteria donor kidneys that were transplanted at other Eurotransplant centers after being rejected by our institution.
World J Urol. 2013 Aug;31(4):947-52. doi: 10.1007/s00345-012-0929-7. Epub 2012 Aug 18.
PubMed PMID: 22903774.

Giessing M.
Preface. European Association of Urology (EAU).
Transplant Proc. 2013 Apr;45(3):1219. doi: 10.1016/j.transproceed.2013.03.018.
PubMed PMID: 23622663.

Haldrup C, Mundbjerg K, Vestergaard EM, Lamy P, Wild P, Schulz WA, Arsov C, Visakorpi T, Borre M, Høyer S, Orntoft TF, Sørensen KD.
DNA methylation signatures for prediction of biochemical recurrence after radical prostatectomy of clinically localized prostate cancer.
J Clin Oncol. 2013 Sep 10;31(26):3250-8. doi: 10.1200/JCO.2012.47.1847. Epub 2013 Aug 5.
PubMed PMID: 23918943.

Hatina J, Fernandes MI, Hoffmann MJ, Zeimet AG.
Cancer Stem Cells - Basic Biological Properties and Experimental Approaches.
eLS 2013 Sep: 1-14. doi 10.1002/9780470015902.a0021164.pub2

Heidenreich A, Scholz HJ, Rogenhofer S, Arsov C, Retz M, Müller SC, Albers P, Gschwend J, Wirth M, Steiner U, Miller K, Heinrich E, Trojan L, Volkmer B, Honecker F, Bokemeyer C, Keck B, Otremba B, Ecstein-Fraisse E, Pfister D.
Cabazitaxel plus prednisone for metastatic castration-resistant prostate cancer progressing after docetaxel: results from the German compassionate-use programme.
Eur Urol. 2013 Jun;63(6):977-82. doi: 10.1016/j.eururo.2012.08.058. Epub 2012 Sep 3.
PubMed PMID: 23116658.

Jones R, Vuky J, Elliott T, Mead G, Arranz JA, Chester J, Chowdhury S, Dudek AZ, Müller-Mattheis V, Grimm MO, Gschwend JE, Wülfing C, Albers P, Li J, Osmukhina A, Skolnik J, Hudes G.
Phase II study to assess the efficacy, safety and tolerability of the mitotic spindle kinesin inhibitor AZD4877 in patients with recurrent advanced urothelial cancer.
Invest New Drugs. 2013 Aug;31(4):1001-7. doi: 10.1007/s10637-013-9926-y. Epub 2013 Jan 18.
PubMed PMID: 23329066.

Keck B, Merseburger AS, Stohr R, Fussel S, Hoffmann MJ, Schmid S, Olbert P, Hartmann A, Nawroth R.
Bladder cancer in focus. Update 2012 of the German Bladder Cancer Association.
Urologe 2013 Mar;52(3):373-377.

Kocot A, Giessing M.
Increasing the donor and recipient pool-expanded criteria in living kidney donors.
Transplant Proc. 2013 Apr;45(3):1245-7. doi: 10.1016/j.transproceed.2013.02.025.
PubMed PMID: 23622669.

Koychev D, Honecker F, Bokemeyer C, Albers P.
Treatment of patients with cisplatin-refractory germ cell tumors.
Onkologe 2013 Jul;19(7):564-567.

Kreimer U, Schulz WA, Koch A, Niegisch G, Goering W.
HERV-K and LINE-1 DNA Methylation and Reexpression in Urothelial Carcinoma.
Front Oncol. 2013 Sep 26;3:255. doi: 10.3389/fonc.2013.00255. eCollection 2013.
PubMed PMID: 24133654; PubMed Central PMCID: PMC3783855.

Kristiansen G, Stockle M, Albers P, Schmidberger H, Martus P, Wellek S, Harter M, Bussar-Maatz R, Wiegel T.
The importance of pathology in the German prostate cancer study PREFERE.
Pathologe 2013 Sep;34(5):449-460.

Lavery HJ, Stensland KD, Niegisch G, Albers P, Droller MJ.
Pathological T0 Following Radical Cystectomy with or without Neoadjuvant Chemotherapy: A Useful Surrogate.
J Urol. 2013 Dec 1. pii: S0022-5347(13)06009-6. doi: 10.1016/j.juro.2013.10.142. [Epub ahead of print]
PubMed PMID: 24300483.

Lorch A.
[Metastatic prostate cancer: new insights and developments].
Dtsch Med Wochenschr. 2013 Apr;138(14):703-6. doi: 10.1055/s-0032-1332995. Epub 2013 Mar 26. Review. German.
PubMed PMID: 23533034.

Lorch A, Albers P.
[Update on first-line and relapse chemotherapy for testicular cancer].
Urologe A. 2013 Nov;52(11):1547-8, 1550-5. doi: 10.1007/s00120-013-3251-0. German.
PubMed PMID: 24126502.

Lorch A, Beyer J, Bokemeyer C.
Significance of high-dose chemotherapy (HDCT) for male germ cell tumors.
Onkologe 2013 Jul;19(7):568-572.

Bramann EL, Willenberg HS, Hildebrandt B, Muller-Mattheis V, Schott M, Scherbaum WA, Haase M.
Griseofulvin Inhibits the Growth of Adrenocortical Cancer Cells In Vitro.
Hormone Metabol Res. 2013;45(4):297-300.

Nichols CR, Roth B, Albers P, Einhorn LH, Foster R, Daneshmand S, Jewett M, Warde P, Sweeney CJ, Beard C, Powles T, Tyldesley S, So A, Porter C, Olgac S, Fizazi K, Hayes-Lattin B, Grimison P, Toner G, Cathomas R, Bokemeyer C, Kollmannsberger C.
Active surveillance is the preferred approach to clinical stage I testicular cancer.
J Clin Oncol. 2013 Oct 1;31(28):3490-3. doi: 10.1200/JCO.2012.47.6010. Epub 2013 Sep 3.
PubMed PMID: 24002502.

Niegisch G, Knievel J, Koch A, Hader C, Fischer U, Albers P, Schulz WA.
Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.
Urol Oncol. 2013 Nov;31(8):1770-9. doi: 10.1016/j.urolonc.2012.06.015. Epub 2012 Sep 1.
PubMed PMID: 22944197.

Niegisch G, Lorch A, Droller MJ, Lavery HJ, Stensland KD, Albers P.
Neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: which patients benefit?
Eur Urol. 2013 Sep;64(3):355-7. doi: 10.1016/j.eururo.2013.06.002. Epub 2013 Jun 12.
PubMed PMID: 23773558.

Pfister D, Albers P, Busch J, Dieckmann KP, Honecker F, Krege S, Winter C, Schmelz H, Schrader M, Heidenreich A. Deutsch Hodentumorgrp.
Adjunctive surgeries in postchemotherapy retroperitoneal lymph node dissection in, PC-RPLND, patients with non seminomatous germ cell cancer, NSGCC after cisplatin based chemotherapy.
Onkologie 2013 Oct;36(S7):114-114.

Pfister D, Albers P, Busch J, Dieckmann KP, Honecker F, Krege S, Winter C, Schmelz H, Schrader M, Heidenreich A. Deutsch Hodentumorgrp.
Pathohistological findings in patients with nonseminomatous germ cell tumors (NSGCT) who undergo poet-chemotherapy retroperitoneal lymph node dissection (PC-RPLND) for small tumours.
Onkologie 2013 Oct;36(S7):114-114.

Pfister D, Albers P, Busch J, Dieckmann KP, Schmez H, Krege S, Winter C, Schrader M, Honecker F, Heidenreich A. Deutsche Hodentumorgrp.
Comparing the perioperative management of postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) in patients with pure simonomatous and non seminomatous germ cell tumours, NSGCT.
Onkologie 2013 Oct;36(S7):81-81.

Pond GR, Agarwal N, Bellmunt J, Choueiri TK, Qu AQ, Fougeray R, Vaughn D, James ND, Salhi Y, Albers P, Niegisch G, Galsky MD, Wong YN, Ko YJ, Stadler WM, O'Donnell PH, Sridhar SS, Vogelzang NJ, Necchi A, di Lorenzo G, Sternberg CN, Mehta AN, Sonpavde G.
A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma.
BJU Int. 2013 Nov 13. doi: 10.1111/bju.12564. [Epub ahead of print]
PubMed PMID: 24219029.

Pond GR, Bellmunt J, Fougeray R, Choueiri TK, Qu AQ, Niegisch G, Albers P, Di Lorenzo G, Salhi Y, Galsky MD, Agarwal N, Necchi A, Sonpavde G.
Impact of response to prior chemotherapy in patients with advanced urothelial carcinoma receiving second-line therapy: implications for trial design.
Clin Genitourin Cancer. 2013 Dec;11(4):495-500. doi: 10.1016/j.clgc.2013.04.025. Epub 2013 Jun 22.
PubMed PMID: 23800847.

Powles T, Bascoul-Mollevi C, Kramar A, Lorch A, Beyer J.
Prognostic impact of LDH levels in patients with relapsed/refractory seminoma.
J Cancer Res Clin Oncol. 2013 Aug;139(8):1311-6. doi: 10.1007/s00432-013-1442-0. Epub 2013 May 3.
PubMed PMID: 23640062.

Quentin M, Schimmöller L, Arsov C, Rabenalt R, Antoch G, Albers P, Blondin D.
Increased signal intensity of prostate lesions on high b-value diffusion-weighted images as a predictive sign of malignancy.
Eur Radiol. 2014 Jan;24(1):209-13. doi: 10.1007/s00330-013-2999-3. Epub 2013 Aug 31.
PubMed PMID: 23995881.

Quentin M, Schimmöller L, Arsov C, Rabenalt R, Antoch G, Albers P, Blondin D.
3-T in-bore MR-guided prostate biopsy based on a scoring system for target lesions characterization.
Acta Radiol. 2013 Dec;54(10):1224-9. doi: 10.1177/0284185113492972. Epub 2013 Jul 22.
PubMed PMID: 23878360.

Ryan CJ, Smith MR, de Bono JS, Molina A, Logothetis CJ, de Souza P, Fizazi K, Mainwaring P, Piulats JM, Ng S, Carles J, Mulders PFA, Basch E, Small EJ, Saad F, Schrijvers D, Van Poppel H, Mukherjee SD, Suttmann H, Gerritsen WR, Flaig TW, George DJ, Yu EY, Efstathiou E, Patnuck A, Winquist E, Higano CS, Taplin ME, Park Y, Kheoh T, Griffin T, Scher HI, Rathkopf DE. COU-AA-302 Investigators.
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy.
New Engl J Med. 2013 Jan;368(2):138-148.

Schimmöller L, Quentin M, Arsov C, Lanzman RS, Hiester A, Rabenalt R, Antoch G, Albers P, Blondin D.
Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard.
Eur Radiol. 2013 Nov;23(11):3185-90. doi: 10.1007/s00330-013-2922-y. Epub 2013 Jun 12.
PubMed PMID: 23756958.

Sonpavde G, Pond GR, Fougeray R, Choueiri TK, Qu AQ, Vaughn DJ, Niegisch G, Albers P, James ND, Wong YN, Ko YJ, Sridhar SS, Galsky MD, Petrylak DP, Vaishampayan UN, Khan A, Vogelzang NJ, Beer TM, Stadler WM, O'Donnell PH, Sternberg CN, Rosenberg JE, Bellmunt J.
Time from prior chemotherapy enhances prognostic risk grouping in the second-line setting of advanced urothelial carcinoma: a retrospective analysis of pooled, prospective phase 2 trials.
Eur Urol. 2013 Apr;63(4):717-23. doi: 10.1016/j.eururo.2012.11.042. Epub 2012 Nov 26.
PubMed PMID: 23206856.

Uche-Holub E, Thierling U, Giessing M, Neumann NJ.
[Intracavernous injection: a treatment modality for erectile dysfunction].
Hautarzt. 2013 Apr;64(4):232-3. doi: 10.1007/s00105-013-2558-5. German.
PubMed PMID: 23576167.

Vinarskaja A, Schulz WA, Ingenwerth M, Hader C, Arsov C.
Association of PITX2 mRNA down-regulation in prostate cancer with promoter hypermethylation and poor prognosis.
Urol Oncol-Semin Ori. 2013 Jul;31(5):622-627.

Werminghaus P, Haase M, Hornsby PJ, Schinner S, Schott M, Malendowicz LK, Lammers BJ, Goretzki PE, Müller-Mattheis V, Markus Giessing, Willenberg HS.
Hedgehog-signaling is upregulated in non-producing human adrenal adenomas and antagonism of hedgehog-signaling inhibits proliferation of NCI-H295R cells and an immortalized primary human adrenal cell line.
J Steroid Biochem Mol Biol. 2014 Jan;139:7-15. doi: 10.1016/j.jsbmb.2013.09.007. Epub 2013 Sep 21.
PubMed PMID: 24063979.

Wiegel T, Albers P, Bussar-Maatz R, Gottberg A, Härter M, Kieser M, Kristiansen G, Nettekoven G, Martus P, Schmidberger H, Wellek S, Stöckle M.
[PREFERE - the German prostatic cancer study: questions and claims surrounding study initiation in January 2013].
Urologe A. 2013 Apr;52(4):576-9. doi: 10.1007/s00120-013-3186-5. German.
PubMed PMID: 23571802.

Winter C, Albers P.
Clinical stage I nonseminoma.Onkologe 213 Jul;19(7):557-563.